Om

Biomm S.A. is a prominent biotechnology company that focuses on the development, manufacturing, and commercialization of biopharmaceutical products. Its core mission is to address unmet healthcare needs by providing innovative bio-drugs and treatment solutions. The company plays a significant role in the healthcare sector, especially in areas related to chronic diseases, oncology, and infectious diseases, offering a portfolio that includes insulin and other bio-product lines. Biomm S.A. operates primarily in the Brazilian market, where it contributes to local biotech advancements and supports the national healthcare system by enabling access to high-quality biopharmaceuticals. Established with a robust research and development foundation, Biomm is known for its cutting-edge facilities and strategic partnerships which enhance its capability to deliver competitive biotechnological solutions. The company stands out in the financial market due to its pioneering role in biopharma manufacturing, bolstering regional healthcare infrastructure and potentially impacting global biotech innovations through strategic expansions and collaborations.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I BIOMM MED ENDAVU: Køb Biomm ($BIOM3) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Biomm, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.